CytomX Therapeutics, Inc. — Form D

CytomX Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-17. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Alan AshworthDirectorSOUTH SAN FRANCISCO, CA
Halley GilbertDirectorSOUTH SAN FRANCISCO, CA
Elaine JonesDirectorSOUTH SAN FRANCISCO, CA
Sean McCarthyDirectorSouth San Francisco, CA
James MeyersDirectorSOUTH SAN FRANCISCO, CA
Mani MohindruDirectorPittsburgh, PA
Matthew YoungDirectorJupiter, FL
Marcia BelvinExecutive OfficerSOUTH SAN FRANCISCO, CA
Wayne ChuExecutive OfficerSOUTH SAN FRANCISCO, CA
Jeff LandauExecutive OfficerSOUTH SAN FRANCISCO, CA
Sean McCarthyExecutive OfficerSouth San Francisco, CA
Chris OgdenExecutive OfficerSOUTH SAN FRANCISCO, CA
Lloyd RowlandExecutive OfficerSOUTH SAN FRANCISCO, CA
Nancy StaglianoDirectorSouth San Francisco, CA
Nancy StaglianoExecutive OfficerSouth San Francisco, CA
Frederick GluckDirectorWestlake Village, CA
Frederick GluckExecutive OfficerWestlake Village, CA
Gary WilcoxDirectorThousand Oaks, CA
Tim W ShannonDirectorNew Haven, CT
Rachel V HumphreyDirectorSouth San Francisco, CA
Hoyoung W HuhDirectorSouth San Francisco, CA
Neil W ExterDirectorSouth San Francisco, CA
Alan HeegerDirectorSanta Barbara, CA
Elaine V JonesDirectorAustin, TX
Frederick W GluckDirectorThousand Oaks, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2015-06-25D$70.0M$70.0M
2015-01-06D$30.0M$16.5M
2012-08-10D$26.0M$12.6M
2010-09-28D$653K$653K
2010-09-28D$30.0M$10.0M
2010-09-28D$2.7M$2.7M
2010-09-28D$102K$102K
2010-09-28D$525K$525K

More